Guangzhou Baiy reported CNY2.31B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Aspen Pharmacare ZAR 6.06B 867M Jun/2024
Cipla INR 14.03B 4.48B Jun/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Jiangsu Hengrui CNY 2.56B 259.7M Mar/2026
Kalbe Farma IDR 1.44T 141.07B Mar/2026
Richter Gedeon HUF 83.47B 692M Mar/2026
Sh Fosun Pharma CNY 1.57B 128.23M Dec/2025
Sh Pharmaceutical CNY 5.01B 2.41B Jun/2025
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026